A Phase I, Open-label, Dose-escalation, Safety Study of the Combination of EPO906 and Radiation Therapy for the Treatment of Patients With Cancer.
Phase of Trial: Phase I
Latest Information Update: 11 Mar 2011
At a glance
- Drugs Patupilone (Primary)
- Indications Head and neck cancer; Solid tumours
- Focus Adverse reactions
- 19 Aug 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 19 Aug 2010 Actual end date (Jul 2009) added as reported by ClinicalTrials.gov.
- 04 Jun 2009 New trial record.